D.A. Davidson & Co’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.81M | Buy |
30,619
+8,198
| +37% | +$1.54M | 0.03% | 387 |
|
|
2026
Q1 | $4.42M | Buy |
22,421
+10,262
| +84% | +$1.98M | 0.03% | 435 |
|
|
2025
Q4 | $2.24M | Sell |
12,159
-3,078
| -20% | -$540K | 0.01% | 633 |
|
|
2025
Q3 | $2.34M | Sell |
15,237
-3,345
| -18% | -$506K | 0.02% | 598 |
|
|
2025
Q2 | $2.6M | Buy |
18,582
+555
| +3% | +$77.8K | 0.02% | 532 |
|
|
2025
Q1 | $2.65M | Sell |
18,027
-31
| -0.2% | -$4.49K | 0.02% | 493 |
|
|
2024
Q4 | $2.37M | Buy |
18,058
+5,128
| +40% | +$718K | 0.02% | 506 |
|
|
2024
Q3 | $2.01M | Sell |
12,930
-3,917
| -23% | -$632K | 0.02% | 547 |
|
|
2024
Q2 | $2.63M | Buy |
16,847
+1,467
| +10% | +$221K | 0.02% | 460 |
|
|
2024
Q1 | $2.08M | Sell |
15,380
-376
| -2% | -$49.8K | 0.02% | 520 |
|
|
2023
Q4 | $2.12M | Buy |
15,756
+3,139
| +25% | +$408K | 0.02% | 487 |
|
|
2023
Q3 | $1.71M | Buy |
12,617
+907
| +8% | +$124K | 0.02% | 515 |
|
|
2023
Q2 | $1.68M | Sell |
11,710
-28
| -0.2% | -$4.12K | 0.02% | 529 |
|
|
2023
Q1 | $1.63M | Sell |
11,738
-823
| -7% | -$111K | 0.02% | 516 |
|
|
2022
Q4 | $1.71M | Buy |
12,561
+193
| +2% | +$24.2K | 0.02% | 485 |
|
|
2022
Q3 | $1.36M | Buy |
12,368
+1,627
| +15% | +$206K | 0.02% | 501 |
|
|
2022
Q2 | $1.42M | Buy |
10,741
+876
| +9% | +$115K | 0.02% | 508 |
|
|
2022
Q1 | $1.31M | Buy |
9,865
+379
| +4% | +$45.5K | 0.01% | 565 |
|
|
2021
Q4 | $1.11M | Sell |
9,486
-306
| -3% | -$36K | 0.01% | 626 |
|
|
2021
Q3 | $1.18M | Buy |
9,792
+932
| +11% | +$108K | 0.01% | 583 |
|
|
2021
Q2 | $1.06M | Buy |
8,860
+548
| +7% | +$60.1K | 0.01% | 613 |
|
|
2021
Q1 | $827K | Sell |
8,312
-315
| -4% | -$31.7K | 0.01% | 644 |
|
|
2020
Q4 | $865K | Sell |
8,627
-3
| -0% | -$318 | 0.01% | 542 |
|
|
2020
Q3 | $946K | Buy |
8,630
+536
| +7% | +$59.6K | 0.02% | 460 |
|
|
2020
Q2 | $856K | Sell |
8,094
-73
| -0.9% | -$7.54K | 0.02% | 477 |
|
|
2020
Q1 | $728K | Sell |
8,167
-615
| -7% | -$57.9K | 0.01% | 513 |
|
|
2019
Q4 | $877K | Sell |
8,782
-205
| -2% | -$19.3K | 0.01% | 536 |
|
|
2019
Q3 | $801K | Buy |
8,987
+92
| +1% | +$7.98K | 0.01% | 533 |
|
|
2019
Q2 | $734K | Sell |
8,895
-1,347
| -13% | -$106K | 0.01% | 540 |
|
|
2019
Q1 | $821K | Sell |
10,242
-5,276
| -34% | -$416K | 0.01% | 555 |
|
|
2018
Q4 | $1.18M | Sell |
15,518
-803
| -5% | -$62.7K | 0.02% | 443 |
|
|
2018
Q3 | $1.29M | Buy |
16,321
+613
| +4% | +$46.4K | 0.02% | 452 |
|
|
2018
Q2 | $1.1M | Buy |
15,708
+5,877
| +60% | +$423K | 0.02% | 467 |
|
|
2018
Q1 | $688K | Buy |
9,831
+576
| +6% | +$39.9K | 0.01% | 586 |
|
|
2017
Q4 | $642K | Buy |
9,255
+966
| +12% | +$65.1K | 0.01% | 584 |
|
|
2017
Q3 | $561K | Buy |
8,289
+545
| +7% | +$34.4K | 0.01% | 642 |
|
|
2017
Q2 | $527K | Buy |
7,744
+4,518
| +140% | +$295K | 0.01% | 610 |
|
|
2017
Q1 | $200K | Sell |
3,226
-834
| -21% | -$48.5K | ﹤0.01% | 937 |
|
|
2016
Q4 | $220K | Sell |
4,060
-7,490
| -65% | -$425K | 0.01% | 961 |
|
|
2016
Q3 | $757K | Buy |
11,550
+9,397
| +436% | +$614K | 0.02% | 528 |
|
|
2016
Q2 | $127K | Buy |
2,153
+50
| +2% | +$2.9K | ﹤0.01% | 1034 |
|
|
2016
Q1 | $116K | Sell |
2,103
-97
| -4% | -$5.83K | ﹤0.01% | 1060 |
|
|
2015
Q4 | $147K | Buy |
2,200
+6
| +0.3% | +$393 | ﹤0.01% | 956 |
|
|
2015
Q3 | $138K | Sell |
2,194
-238
| -10% | -$15.7K | ﹤0.01% | 965 |
|
|
2015
Q2 | $152K | Buy |
2,432
+85
| +4% | +$5.82K | 0.01% | 968 |
|
|
2015
Q1 | $159K | Buy |
2,347
+272
| +13% | +$18.9K | 0.01% | 953 |
|
|
2014
Q4 | $144K | Sell |
2,075
-98
| -5% | -$7.02K | ﹤0.01% | 984 |
|
|
2014
Q3 | $154K | Sell |
2,173
-327
| -13% | -$23.9K | 0.01% | 962 |
|
|
2014
Q2 | $184K | Sell |
2,500
-4,762
| -66% | -$344K | 0.01% | 927 |
|
|
2014
Q1 | $470K | Sell |
7,262
-952
| -12% | -$61.5K | 0.02% | 626 |
|
|
2013
Q4 | $485K | Buy |
8,214
+1,359
| +20% | +$73.8K | 0.02% | 588 |
|
|
2013
Q3 | $354K | Sell |
6,855
-530
| -7% | -$26.6K | 0.02% | 563 |
|
|
2013
Q2 | $348K | Buy |
+7,385
| New | +$376K | 0.02% | 547 |
|
Other funds holding AZN
EP
IA
D.A. Davidson & Co's AZN Position: Q2 2026 in Review
D.A. Davidson & Co increased its AstraZeneca (AZN) stake by 37% in Q2 2026, buying an estimated $1.54M and bringing the position to 30,619 shares worth $5.81M. The position accounts for 0.03% of the portfolio, ranked #387.
D.A. Davidson & Co first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- D.A. Davidson & Co held 30,619 shares of AstraZeneca worth $5.81M as of Q2 2026.
- D.A. Davidson & Co bought 8,198 AstraZeneca shares in Q2 2026, an estimated $1.54M.
- AstraZeneca made up 0.03% of D.A. Davidson & Co's portfolio in Q2 2026, its #387 holding.
- D.A. Davidson & Co first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.